Edwards Lifesciences Sees Q1 Adj. EPS $0.54-$0.62 vs $0.60 Est., Sales $1.27B-$1.35B vs $1.36B Est.; Sees FY22 Adj. EPS $2.50-$2.65 vs $2.58 Est., Sales $5.5B-$6B vs $5.82B Est.